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Abstract
Background: The financial burden of cancers has profound effects and there is a clear need to explore the issue
from different perspectives and for different population groups. This study aimed at investigating inpatient cancer
care (ICC) burden in Anhui, a typical inland province of China.
Methods: The study collected data through a household survey conducted during April to November, 2014 using
cluster-randomized sampling and a structured questionnaire administered face-to-face by trained interviewers.
Results: The survey covered 60,678 urban and rural residents and 318 person-times of ICC during the past year.
Age-adjusted annual person-times and days of ICC per thousand population added up to 4.24 and 76.78
respectively and urban residents showed significantly greater admission rates and length of stay than that of rural
ones. Total ICC expenditures accounted for 13.30 % of all that of inpatient care for the whole population. Per-case
direct and indirect costs of all types of cancers were estimated as 10365.1 and 929.9 RMB. Per-case total cost on ICC
at township hospitals was 2142.3 RMB and at province level hospitals, 17133.0 RMB. Significant variations in per-case
ICC expenditures also existed between patients with different household income and type of medical insurance
systems, but patients suffering from different types of cancers. Out-of-pocket payment due to ICC turned out to be
catastrophic for 20.6 % of all cancer patients and 65.2 % for other medical insurance, 45.6 % for enrollees of urban
and rural medical insurance, 43.2 % for the 65 to 74 years old. Multi regression revealed statistically significant
association between ICC costs and education, reimbursement ratio, household income and level of hospital.
Conclusions: Cancers characterize low incidence, moderate service use and high expenses. There exist substantial
differences between subgroups and part of these variations cannot be explained by pathological factors. ICC
expenses are catastrophic in nature to a large part of patients. There is a clear need for more effectively regulating
cancer-related medical practices and service seeking behaviors.
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Background
Cancers incur tremendous financial burden on patients,
their relatives and health care systems. Estimated annual
total cost of cancers added up from $1643 to $7705 per
patient [1–4]. Estimated per-case cancer expenditure
ranged from a few percent to several times of the family
income of the affected [5]. Cancers incur financial bur-
dens through several ways. These include direct input
on the diagnosis and treatment of the diseases, indirect
costs spent on travel to and from service providers, sup-
plementary nutrients and nursing care etc., and income
loss due to disease-related absenteeism or retirement,
unemployment, bankruptcies and discriminations [1, 4,
6–13]. Cancer expenditures have witnessed rapid in-
crease during the past decades [14, 15]. And this fast
growing trend is most likely to continue in the future.
On the one hand, aging population and deteriorating en-
vironments and lifestyles are causing an increasing can-
cer epidemiology [16]. On the other, people diagnosed
with cancers survive longer and longer due to improving
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early detection technologies, expanding screening ser-
vices, and emerging new therapies [16, 17]. Besides,
these are paralleled by surging overall and healthcare
consumption in general and relatively loose cost-
containment and clinical guidelines on cancer services
in particular.
Perhaps, the first and hardest hit by financial burden
of cancers (FBC) may be the patients and their relatives,
for whom it has profound effects and implications by
various means. First, FBC affects the outcomes of cancer
case management. Zafar and colleagues conducted a co-
hort study of 1000 colorectal or lung cancer patients,
and found that financial burden was closely related to
the patients’ health-related quality of life [18]. The study
by Zarogoulidou et al. discovered significant relation-
ships between direct cost on chemotherapy and overall
survival, quality of life and treatment outcome [19]. Sec-
ond, FBC influences cancer treatment decision-making
and compliance. Streeter and coworkers reported that
patients with cost sharing greater than $500 were 4.46
times more likely to abandon oral oncolytic treatment
than patients with cost sharing of $100 or less [20].
Similarly, Zafar et al. found that, when faced with finan-
cial difficulties, cancer patients tend to take less than the
prescribed amount of medication (20 %), partially fill
prescriptions (19 %) or avoid filling prescriptions
altogether (24 %) [21]. Third, FBC aggravates cancer in-
duced negative worries and feelings. A cross-sectional
survey of cancer patients seeking financial assistance
from the HealthWell Foundation revealed that higher fi-
nancial burden was also associated with dissatisfaction
with the technical quality of health care [22].
Given the magnitude and influences of FBC, there is a
clear need to explore the issue from different perspec-
tives and for different population groups. This especially
applies to China, a nation with the largest population
and number of cancer cases and the least insurance
schemes for cancer care. Most pharmaceutical regimens
and surgical and radiological therapies for cancer pa-
tients in China fall out of the government’s list of essen-
tial medicine and are hence ineligible for any kinds of
government subsidy. Compared with the emerging lit-
erature documenting FBC and its influences in other
countries (mostly the developed nations), there is a gen-
eral paucity in publications on the same issue in China.
This study aimed at investigating inpatient cancer care
(ICC) burden in Anhui, a typical inland province of
China, using data derived from a household survey.
Methods
Data collection
The study used part of the data obtained through a
household survey conducted during April to November,
2014 in Anhui, a typical inland province of China. The
survey aimed at assessing health services need and
utilization by urban and rural residents and informing
health resources planning. It adopted a structured ques-
tionnaire administered face-to-face at the respondents’
households by trained interviewers. Variables surveyed
comprised two main aspects, i.e., socio-demographics
and healthcare utilization and costs. The former con-
sisted of age, gender, education, household income, type
of residence (urban vs. rural), and insurance(s) enrolled.
The latter solicited information about all episodes of
health services use happened during the past 12 months
by all the household members including type of service
(i.e., outpatient or inpatient care) received, name and
classification code of the disease which caused the ser-
vice use, self-reported direct and indirect costs incurred
due to the service, and level of the service provider. Se-
lection of the households employed a stratified random
sampling proceeded in two stages. Stage 1 classified all
the counties and cities in Anhui province into southern,
northern and middle areas. Stage 2 randomly selected: a)
6 counties and 6 cities from each of the 3 areas (36
counties/cities in total); b) 5 communities from each of
the counties or cities; c) 120 household from each of the
communities.
Data analysis
The study conducted mainly descriptive analysis using
SPSS version 16. It calculated, for different groups,
the average values of: a) annual person-times and
person-days of ICC; b) per case ICC expenditures; c)
percentages of ICC expenditure versus all diseases;
and d) ICC expenditure reaching given cutoff percent-
ages of family income. It also performed multivariate
regression analysis and power tests to detect statis-
tical differences using χ2 test, or rank sum test or
ANOVA with α < 0.05 being considered significant. In
order to control age-induced confounding, the study
groups were standardized using the national average
age distributions in 2010 generated from the latest
China population census. Given that the direct and
indirect health expenditures displayed severely skewed
distributions, they were translated into normal distri-
butions to enable statistical power tests using
Ln(Ln(x)), where x stands for individual health expen-
ditures. To facilitate international comparison, the in-
patient care expenditures in Chinese yuan (RMB)
were translated into US dollars ($) at $1 = 6.2 RMB,
the average exchange rate for the year of 2013 when
the survey was carried out. Considering that re-
searchers hold different views about how to define
catastrophic health expenditures [23], the study calcu-
lated catastrophic ICC expenditures using a series of
cutoff values, i.e., 20, 30, 40 and 50 % of total house-
hold income.
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Ethics, consent and permissions
The study protocol had been reviewed and approved by
the Biomedical Ethics Committee of Anhui Medical Uni-
versity. Participation of subjects was voluntary and writ-
ten consent was obtained from all participants prior to
data collection.
Results
Characteristics of subjects surveyed and ICC cases
The household survey reached response rate of 86.68 %
and obtained data about 60,678 residents consisting of
29,980 males and 30,698 females and 30,597 urban and
30,081 rural residents (Table 1). They reported a total of
318 person-times of ICC during the past year including
178 and 140 person-times for male and female patients
and 171 and 147 person-times for urban and rural pa-
tients respectively.
Person-times and person-days of ICC per thousand
population
Table 2 provides standardized figures about person-
times and person-days of ICC in the past year by
different groups. On average, 1000 people studied in-
curred 4.24 person-times of hospital admissions and
76.78 person-days of ICC in the past 12 months and
urban residents presented significantly greater admission
rates and length of stay (days) than that of rural respon-
dents. The two indicators showed substantial discrepan-
cies between different subgroups varying from 0.00
person-times (for rural enrollees of city employee med-
ical insurance) to 22.11 person-times (for males aged
75 years or over) and from 13.03 person-days (for resi-
dents with secondary or higher education in rural areas)
to 382.28 person-days (for males aged 75 years or over)
respectively. The majority (83 out of 116) of these differ-
ences were statistically significant with clear trends being
observable within age subgroups of males, females,
urban residents, and rural residents.
ICC expenditures by cancer types and population groups
Figure 1 and Appendix 1 and 2 show average and per-
centages of ICC expenditures by different cancer types
and population groups. Putting together, per-case direct
and indirect costs of all types of cancers were estimated
Table 1 Descriptive statistics of standardized inpatient cancer care cases and subjects surveyed
Grouping criteria Hospital admissions (person-times) Subjects surveyed (×1000)
Total Males Females Urban Rural Total Males Females Urban Rural
Age (years)
Under 45 70 14 56 48 22 31.05 15.42 15.63 16.08 14.96
45 to 54 62 29 33 37 25 10.45 4.88 5.57 5.40 5.06
55 to 64 100 67 33 42 58 9.81 4.90 4.91 4.64 5.18
65 to 74 44 33 11 22 22 6.06 3.19 2.86 2.92 3.14
75 or over 42 35 7 22 20 3.31 1.58 1.73 1.57 1.74
Type of health insurance
NCMC 126 73 51 35 91 35.69 17.32 18.37 12.77 22.92
CEMI 42 18 22 41 0 6.82 3.87 2.95 6.34 0.48
CRMI 39 9 34 37 1 6.26 2.78 3.48 5.66 0.60
URMI 13 9 4 2 11 4.92 2.40 2.52 1.71 3.21
Others 16 9 7 11 4 6.98 3.61 3.37 4.12 2.86
Household income (quartile)
Q1 53 27 26 18 33 10.75 5.32 5.43 4.68 6.07
Q2 70 23 49 48 22 19.19 9.39 9.80 8.92 10.27
Q3 78 45 32 42 36 16.80 8.28 8.52 9.08 7.73
Q4 72 37 33 48 26 13.88 6.96 6.92 7.88 6.01
Education
No education 41 19 22 22 20 17.51 6.53 10.97 7.28 10.23
Primary school 73 39 26 23 49 16.55 8.30 8.25 7.28 9.27
Middle school 71 41 20 35 38 16.62 9.40 7.22 8.69 7.93
Secondary or higher school 58 21 33 55 6 10.00 5.75 4.25 7.35 2.65
Total 257 121 135 146 111 60.68 29.98 30.70 30.60 30.08
Note: NCMC new corporative medical care, CEMI city employee medical insurance, CRMI city resident medical insurance, URMI urban and rural medical insurance
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as 10365.1 RMB (or $1671.8) and 929.9 RMB ($150.0)
respectively. Stomach cancer incurred the highest direct
expenditure (14627.7 RMB or $2359.3) followed by cer-
vical cancer (12741.5 RMB or $2055.1), liver cancer
(10909.0 RMB or $1759.5) and colorectal cancer
(10584.8 RMB or $1707.2); while liver cancer, the high-
est indirect cost (1535.4 RMB or $247.6) followed by
cervical cancer (1520.9 RMB or $245.3), nasopharyngeal
cancer (1344.5 RMB or $216.9), and breast cancer
(1326.3 RMB or $213.9). Most of the mean expenditures
turned out to be smaller than the corresponding stand-
ard deviations (SD) and all mean expenditure, greater
than the corresponding median expenditure. Per-case
ICC expenditures by different groups of patient
characteristics also witnessed similar features, e.g., large
variations across subgroups, greater standard deviations
than means and means than medians. For the 5 categor-
ies of subgroups (e.g., age, household income) listed, 4 of
the intra-group differences in direct and indirect per-
case ICC expenditures were statistically significant (p <
0.05). Some extent of increasing trends (i.e., higher grade
of the grouping variable, higher indirect and indirect ex-
penditure) were observable among subgroups of level of
hospital, household income, and age. All the 318 cancer
ICC caused a total of 3,732,761 ($602058.2) RMB direct
(indirect) costs, with stomach cancers incurred the most
(20.36 %) among all cancer types followed by colorectal
cancer (12.54 %); and the 55 to 64 years (24.34 %)
Table 2 Standardized annual person-times and person-days of inpatient cancer care per thousand populations







Urban Rural P (U vs.
R)
Total Males Females P (M vs
F)
Urban Rural P (U vs
R)
Age (years)
Under 45 2.25 0.91 3.58 <0.001 2.98 1.47 0.005 34.05 23.35 44.61 <0.001 31.63 36.63 <0.001
45 to 54 5.93 5.94 5.93 0.994 6.86 4.94 0.202 126.40 143.10 111.70 <0.001 168.64 81.26 <0.001
55 to 64 10.19 13.67 6.72 0.001 9.06 11.20 0.291 180.98 233.13 128.91 <0.001 191.34 171.75 <0.001
65 to 74 7.26 10.34 3.84 0.003 7.54 7.00 0.805 158.80 219.21 91.49 <0.001 157.08 160.46 0.405
75 or over 12.69 22.11 4.06 <0.001 14.05 11.47 0.509 233.54 382.28 97.33 <0.001 275.21 196.21 <0.001
P (value) <0.001 <0.001 0.026 NA <0.001 <0.001 NA <0.001 <0.001 <0.001 NA <0.001 <0.001 NA
Type of health insurance
NCMC 3.53 4.22 2.78 0.021 2.74 3.97 0.061 54.87 63.05 45.72 <0.001 43.51 60.90 0.032
CEMI 6.16 4.65 7.46 0.131 6.47 0.00 0.076 145.62 152.11 135.65 <0.001 154.34 34.08 <0.001
CRMI 6.23 3.24 9.76 0.002 6.54 1.66 0.142 74.68 83.85 80.73 <0.001 80.74 16.05 <0.001
URMI 2.64 3.75 1.59 0.139 1.17 3.43 0.142 86.95 137.16 45.82 <0.001 32.30 116.34 <0.001
Others 2.29 2.49 2.07 0.714 2.67 1.40 0.259 61.25 56.23 61.65 <0.001 56.18 61.44 <0.001
P (value) <0.001 0.537 <0.001 NA <0.001 0.125 NA <0.001 <0.001 <0.001 NA <0.001 <0.001 NA
Household income (quartile)
Q1 4.93 5.08 4.79 0.828 3.85 5.44 0.235 63.51 66.98 58.44 <0.001 47.75 73.02 <0.001
Q2 3.65 2.45 5.00 0.004 5.38 2.14 <0.001 53.17 48.67 58.08 0.051 72.82 35.64 <0.001
Q3 4.64 5.43 3.76 0.116 4.63 4.66 0.769 73.91 85.42 61.15 <0.001 69.73 78.88 0.083
Q4 5.19 5.32 4.77 0.603 6.10 4.33 0.092 144.32 160.27 129.58 <0.001 157.88 133.54 <0.001
P (value) <0.001 <0.001 0.021 NA 0.008 <0.001 NA <0.001 <0.001 <0.001 NA <0.001 <0.001 NA
Education
No education 2.34 2.91 2.01 0.232 3.02 1.96 0.155 47.00 45.47 44.70 0.378 50.09 45.28 0.052
Primary school 4.41 4.70 3.15 0.112 3.16 5.28 0.039 74.65 76.13 62.51 <0.001 52.94 91.74 <0.001
Middle school 4.27 4.36 2.77 0.092 4.03 4.79 0.457 86.66 100.52 39.69 <0.001 88.96 81.11 <0.001
Secondary or higher
school
5.80 3.65 7.76 0.006 7.48 2.26 0.003 108.23 93.19 119.02 <0.001 140.40 13.03 <0.001
P (value) <0.001 0.327 <0.001 NA <0.001 <0.001 NA <0.001 <0.001 <0.001 NA <0.001 <0.001 NA
Total 4.24 4.04 4.40 0.492 4.77 3.69 0.040 76.78 82.97 70.50 <0.001 82.52 71.97 <0.001
Note: NCMC new corporative medical care, CEMI city employee medical insurance, CRMI city resident medical insurance, URMI urban and rural medical insurance,
the power for the differences in person-times of hospital admissions among different groups was calculated using χ2 test and that in person-days of hospital stay,
rank sum test
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among all age groups, and prefecture hospitals (40.95 %)
among all levels.
Expenditures on inpatient care for cancers vs. all diseases
The 60,678 residents reported 5026 person-times of
inpatient care during the past 12 months. Of these,
ICC episodes accounted for 6.33 %. Table 3 presents
the standardized percentages of inpatient care expen-
ditures due to cancers versus all diseases for all the
study population under concern. Looking at overall
data, the direct and indirect ICC expenditures
accounted for 13.30 and 12.70 % of the inpatient care
expenditures for the whole population studied (N =
60,678). Turning to specific figures for different sub-
groups, the percentages ranged from 2.53 to 25.23 %
(for direct ICC expenditure) or 2.20 to 30.55 % (for
indirect ICC expenditure) with the highest percentage
of direct expenditures being found with urban resi-
dents with secondary or higher education (25.23 %)
followed by rural enrollees of urban and rural medical
insurance (25.21 %), urban patients aged from 45 to
54 years old (24.51 %), female enrollees of city em-
ployee medical insurance (23.48 %), females with sec-
ond high quartile of household income (23.38 %).
Catastrophic features of ICC expenditures
Table 4 compares the standardized percentages of un-
reimbursed ICC expenditures (or expenditures paid
by patients rather than governments or insurance
companies) that had reached 20, 30, 40 and 50 % of
household income respectively. Judging by the World
Health Organization standard (40 % of household in-
come) [24], as high as 20.6 % of the single episode
ICC expenditure turned out to be catastrophic to the
patients. The chances of catastrophic ICC expenditure
witnessed substantial differences among different sub-
groups and ICC expenditure was more likely to be
catastrophic for patients who were males, rural resi-
dents, and enrollees of urban and rural medical
insurance.
Multivariate regression analysis of ICC expenditures
Table 5 provides multivariate regression statistics of
ICC expenditures. Level of hospital and household in-
come showed independent associations with direct,
indirect and total ICC expenditures; while education,
with direct and total expenditures; and region, with
indirect expenditure; and reimbursement ratio, with
indirect and total expenditures.
Fig. 1 ICC expenditures by cancer types and population groups. The colored bars represent the direct expenditures by different groups, while the
light-colored bars added on the right end of the colored ones, indirect expenditures; the size of the colored circles stand for total direct plus
indirect expenditure, while the colored arcs consisting the circles denote percentages of direct plus indirect expenditures by different groups;
NCMC = New corporative medical care; CEMI = city employee medical insurance; CRMI = city resident medical insurance; URMI = urban and rural
medical insurance
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Discussion
This study revealed useful information about ICC in An-
hui, a typical inland province of China. Firstly, the study
highlighted the magnitude of ICC burden on the af-
fected, related and the whole society and that cancers
characterize low incidence, moderate service use and
high expenses. Published incidence rate of all cancers
has been less than 300 in every 100 thousand population
[25]; while our findings of a total of 318 person-times of
ICC out from 60,678 residents within 1 year time trans-
lates into a hospital admission rate as 524.08 per 100
thousand population, almost twice that of total cancer
incidence rate. Similarly, although total ICC episodes
took up only 6.33 % of all inpatient service episodes in
our study, direct ICC expenditure accounted for
10365.14 RMB (or $1672) per person annually and
13.30 % of all inpatient care expenditures for the whole
population; and per case expenditures on ICC turned
out to be 2.63 times that on other diseases. This unique
nature of cancers has a couple of implications. On the
one hand, the relatively low incidence of the epidemic
combined with a general lack of researches on the
service use and costs makes it easy to under-estimated
the overall burden and hence importance of ICC burden.
On the other, the high per case costs may imply oppor-
tunities for service savings as well as quality control. Al-
though our estimated per case costs ($1672) on cancer
falls a little bit higher than the bottom line of the range
of international estimations ($1643 to $7705) in absolute
monetary terms, the proportion of ICC expenditure in
total health expenditure (13.30 %) from our study is
much higher than that from other nations (e.g., 5 % in
the USA) [26]. This may have profound impact on both
the patients and the health systems in China.
Secondly, the current study documented substantial
differences in person-times and person-days of ICC be-
tween different sub-groups. These two indicators
showed a clear increasing trend from younger to older
age groups. This is consistent with epidemiological find-
ings that most cancer incidence rates increase exponen-
tially with age [25]. And co-morbidities may also have
played some roles in the cost differences across the age
groups since the older the age the greater the chances of
the cancer patients to have co-morbidities. This finding
Table 3 Standardized percentage of inpatient care expenditure due to cancers versus all diseases
Grouping criteria Direct expenditure (%) Indirect expenditure (%)
Total Males Females Urban Rural Total Males Females Urban Rural
Age (years)
Under 45 13.91 12.98 14.83 15.10 12.76 17.19 17.38 17.06 18.15 16.32
45 to 54 21.82 21.02 22.55 24.51 18.60 22.90 28.22 17.99 30.55 15.16
55 to 64 18.56 22.05 14.46 19.43 17.55 12.13 11.37 13.14 12.23 12.06
65 to 74 11.72 16.89 6.26 8.91 16.36 11.94 16.51 6.57 5.99 19.07
75 or over 16.84 23.23 7.65 14.75 21.72 15.40 19.27 8.92 13.83 17.19
Type of health insurance
NCMC 9.42 9.07 8.12 7.36 10.35 8.70 8.49 7.99 7.10 9.41
CEMI 19.75 16.87 23.48 20.31 8.48 21.45 20.61 24.90 22.52 1.80
CRMI 17.01 20.88 16.26 16.99 13.60 12.77 11.46 14.89 12.82 10.96
URMI 17.76 14.41 9.69 4.36 25.21 13.53 15.45 8.67 6.43 18.59
Others 17.03 14.23 18.21 20.10 10.14 14.05 12.41 15.09 11.39 18.99
Household income (quartile)
Q1 8.17 2.53 12.84 7.28 8.70 6.49 2.20 9.03 5.44 7.19
Q2 16.89 10.29 23.38 21.81 12.06 18.30 9.86 25.33 26.06 10.63
Q3 12.91 11.98 10.52 13.18 12.41 8.89 9.68 7.20 5.30 12.46
Q4 16.73 16.51 14.44 17.78 16.44 16.44 16.62 15.63 17.27 15.74
Education
No education 11.78 10.58 13.07 12.36 12.48 8.35 9.01 9.24 8.46 9.54
Primary school 13.47 11.79 12.03 10.66 17.28 15.38 12.45 18.91 11.15 20.31
Middle school 13.48 13.06 9.56 13.32 13.52 7.78 8.30 4.53 6.21 9.55
Secondary or higher school 19.76 15.41 7.63 25.23 3.23 24.21 24.77 21.82 30.18 3.77
Total 13.30 11.11 13.34 14.18 12.49 12.70 10.97 13.56 13.41 11.99
Note: NCMC new corporative medical care, CEMI city employee medical insurance, CRMI city resident medical insurance, URMI urban and rural medical insurance
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Table 4 Standardized percentage of inpatient cancer care expenditure reaching given cutoff percentages of family income
Grouping criteria Direct expenditure meeting given % income Total expenditure meeting given % income
20 % 30 % 40 % 50 % 20 % 30 % 40 % 50 %
Age (years)
Under 45 21.4 17.1 14.3 12.9 22.9 20.0 20.0 15.7
45 to 54 41.9 32.3 27.4 22.6 51.6 41.9 33.9 27.4
55 to 64 30.0 22.0 18.0 14.0 36.0 26.0 24.0 18.0
65 to 74 56.8 43.2 43.2 38.6 59.1 50.0 43.2 43.2
75 or over 35.7 19.0 14.3 14.3 40.5 21.4 19.0 14.3
P value 0.002 0.012 0.002 0.004 0.001 0.002 0.034 0.003
Gender
Males 26.6 18.4 16.4 14.0 30.0 21.6 20.1 16.9
Females 24.3 19.7 15.6 13.6 29.3 24.4 20.7 16.1
P value 0.062 0.490 0.298 0.486 0.103 0.658 0.314 0.240
Region
Urban 22.0 16.1 14.0 12.8 26.0 19.9 17.0 14.5
Rural 31.0 23.1 19.1 15.5 35.2 27.5 25.4 19.7
P value 0.070 0.091 0.126 0.348 0.075 0.161 0.082 0.188
Type of health insurance
NCMC 27.8 18.8 15.4 12.4 31.7 23.8 21.1 16.3
CEMI 9.2 8.6 7.6 7.6 12.8 9.2 8.6 8.6
CRMI 20.5 14.8 11.4 9.1 24.3 16.8 14.8 9.1
URMI 50.1 41.9 38.6 36.0 50.1 45.6 45.6 38.6
Others 81.1 65.2 57.2 46.8 88.3 80.4 65.2 57.2
P value <0.001 <0.001 <0.001 0.001 <0.001 <0.001 <0.001 <0.001
Household income (quartile)
Q1 20.4 14.9 12.9 12.5 22.5 17.0 16.6 12.9
Q2 23.0 20.5 18.1 15.7 32.4 24.0 19.6 17.1
Q3 41.7 26.8 21.0 15.7 44.5 33.1 31.1 22.5
Q4 21.5 14.8 12.6 11.4 23.7 17.3 13.7 13.7
P value 0.008 0.091 0.103 0.123 0.005 0.031 0.012 0.153
Level of hospital
Township 15.4 7.7 7.7 7.7 23.1 7.7 7.7 7.7
County 31.1 20.5 17.2 14.8 37.7 24.6 21.3 17.2
Prefecture 43.4 31.9 26.5 23.9 46.9 39.8 34.5 29.2
Provence 31.4 27.1 25.7 20.0 35.7 30.0 28.6 22.9
P value 0.076 0.098 0.164 0.228 0.222 0.025 0.062 0.104
Education
No education 26.8 21.5 19.6 19.1 32.7 25.8 23.8 20.2
Primary school 21.2 15.5 14.0 11.2 23.0 18.5 16.2 13.3
Middle school 28.6 17.5 11.2 7.6 35.5 21.9 16.7 12.4
Secondary or higher school 19.4 16.0 14.5 14.5 21.0 17.9 16.0 16.0
P value 0.001 0.010 0.006 0.001 <0.001 0.003 0.003 0.019
Total 25.9 19.1 16.3 14.0 30.0 23.1 20.6 16.7
Note: NCMC new corporative medical care, CEMI city employee medical insurance, CRMI city resident medical insurance, URMI urban and rural medical insurance,
the power for the differences in the percentages of inpatient cancer care expenditure reaching given cutoff percentages of family income among different groups
was calculated using χ2 test
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leads to an important inference that as China’s popu-
lation ages, ICC burden will grow rapidly. For gender
subgroups, this age-related trend applied only to
males but females. This may be explained mainly by
the difference in types of cancers among males and
females. Breast and cervical cancers accounted for
30.71 % of all the cancers among women. These two
types of cancers are linked, to a large extent via dir-
ect or indirect paths, with reproductive hormones
(e.g., estrogens) that start to decrease after some age
around 50 [27]. Compared with age and gender dis-
crepancies, that may be attributed mainly to differ-
ences in incidence rates, huge variations in person-
times and days of ICC among residents covered by
different insurance schemes merit particular attention
since these differences may due largely to service
utilization rather than physical and pathogenic factors.
In China, it is commonly believed that beneficiaries
of the medical insurance for city employees and resi-
dents enjoy the highest reimbursement ratio and the
loosest process for claiming reimbursement; followed
by the new corporative medical care scheme and
others. This order is consistent with that of per thou-
sand capita ICC person-times and days indicating that
medical insurance systems may have played an im-
portant role in shaping ICC utilization. Although the
differences between subgroups of household income
and education were statistically significant, they did
not exhibit clear trend. This may because income and
education exerted mixed effects on ICC use since
higher income and education may mean not only bet-
ter ability obtaining ICC but also lower chances to
develop cancer(s) [28]. With regard to greater admis-
sion rates and length of stay (days) for urban verses
rural residents, possible explanations may include
higher total cancer incidence rate, easier access to
ICC, and better household income, education and in-
surance etc. in urban than rural areas.
Thirdly, the study revealed noteworthy characteris-
tics in per case ICC expenditure. The variations in
expenditures on ICC provided by different level of
hospitals turned out to be the greatest among all the
subgroups studied, being 2142 RMB for ICC at town-
ship hospitals compared with 17,133 RMB for ICC at
province level hospitals. This may be explained
mainly by: a) lower level hospitals charged their pa-
tient at much cheaper price [29]; b) patients with
more serious conditions tended to seek ICC from
higher level hospitals [30]. Given such huge gaps,
there is a clear need for guidelines or regulations
directing cancer patients to appropriate level of hospi-
tals. However, China lacks relevant guidance or regu-
lations and selection of hospitals depends primarily
on individual physicians’ experiences or patients’ un-
derstandings. Per case expenditure on ICC also
showed statistically significant variations among pa-
tients with different household income and type of
medical insurance systems. Patients with higher
household income spend more on a single episode of
ICC may because they faced looser financial con-
straint in choosing diagnosis and treatment proce-
dures. The reason why patients belonging to enrollees
of the new corporative medical care and the city resi-
dent medical insurance incurred relatively lower per
case direct expenditure may because mainly that these
two systems had enacted the strictest policies and
audit procedures in refunding medical care expenses
[31]. Although the diagnosis and treatment proce-
dures and regimens vary from cancer to cancer, yet
the differences in per case direct expenditure across
cancer types turned out to be statistically non-
significant. This contradicts similar findings derived
from other countries [32] and merits further re-
searches. It may hint a peculiar phenomenon of ICC
in which treatment decisions were not based primarily
on the need of the patient under concern but on the
Table 5 Multivariate regression analysis of ICC expenditures
Factors Direct expenditure Indirect expenditure Total expenditure
B t P B t P B t P
Constant 1.611 8.404 <0.001 0.805 2.386 0.018 1.630 7.688 <0.001
Age 0.000 0.458 0.648 0.002 1.680 0.094 0.000 0.658 0.511
Gender −0.025 −1.664 0.097 0.032 1.278 0.202 −0.010 −0.607 0.544
Region 0.006 0.441 0.659 0.064 2.631 0.009 0.011 0.708 0.479
Education −0.021 −2.715 0.007 0.005 0.399 0.690 −0.018 −2.090 0.037
Reimbursement ratio 0.000 1.128 0.260 −0.002 −3.155 0.002 −0.002 −6.507 <0.001
Ln (household income) 0.233 2.882 0.004 0.356 2.514 0.012 0.236 2.643 0.009
Level of hospital 0.068 7.768 <0.001 0.080 5.284 <0.001 0.066 6.865 <0.001
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actual or perceived willingness to pay for his or her
treatment.
Fourthly, the study portrayed catastrophic nature of
ICC expenses (Table 4). Expenditures on ICC
accounted for 13.30 % of that on all inpatient care
and per-case expenses on ICC was 2.63 times that on
all other diseases. After excluding expenditures re-
fundable from various insurance systems, as high as
20.6 % of the out-of-pocket payment due to ICC
turned out to be catastrophic to the patients accord-
ing to the World Health Organization standard (40 %
of total household income) [24]. This included only
direct and indirect cost of ICC without taking into
account expenditures on outpatient care, self-care, re-
peated hospital admissions and others. The burden of
ICC was most devastating for patients who were:
enrollees of other and URMI (urban and rural med-
ical insurance) medical insurance systems; 65 to
74 years old and 45 to 54 age group; and prefecture or
higher level hospital patients. Combined with the
common belief that there lack radical cures for can-
cers, this catastrophic nature of ICC expenditures
may make the affected and related feel most hopeless
and helpless [33] and this feeling has profound impli-
cations for clinicians as well as policy-makers.
This study has both strengths and weaknesses. Per-
haps, the biggest advantage of the current study relates
to its “household-based” data collection. Most published
papers addressing inpatient care expenditures belonged
to “hospital-based” investigations [4, 9, 10, 12] and hence
suffered from major selection biases since ICC expendi-
tures vary greatly across hospitals and drawing a sample
of ICC cases from hospitals in proportion to ICC cases
actually happened in the community is almost impos-
sible. Although estimating ICC burden via “household
surveys” avoids the sampling difficulties faced with “hos-
pital-based” studies, it is prone to recall biases. It is very
easy for some respondents to forget part of the expenses
even whole ICC episodes happened during a whole year.
It is also quite often in China that, for fearing of poten-
tial worries or distress, cancer diagnosis are not dis-
closed to part of the household members (especially the
patients themselves). These may have resulted in under
estimations of the ICC costs. Future studies in this re-
gard should take appropriate measures in minimizing
this recall bias, e.g., selection of the most educated or
capable household members as the respondents, use of
carefully designed categories of expenditures as re-
minders, and triangulation. Another drawback of the
study concerns the size of subjects studied. Although the
survey covered 60,678 residents, it identified only 318
ICC episodes which included very limited cases of rear
cancers, e.g., nine cases of liver cancer. So, readers are
well cautioned about the potential statistical variations
interpreting our estimations especially expenditures or
length of stay for subgroups.
Conclusion
Cancers characterize low incidence, moderate service
use and high expenses. There exist substantial differ-
ences between subgroups and part of these variations
cannot be explained by pathological factors. There
are indications that treatment decisions on ICC were
not based primarily on the need of the patient under
concern but on the actual or perceived willingness
to pay. ICC expenses are catastrophic in nature to a
large part of patients. There is a clear need for more
effectively regulating cancer-related medical practices
and service seeking behaviors.
Availability of data and materials
The raw dataset of all the inpatient cancer care cases is
accessible from Additional file 1.
Table 6 Per-case inpatient care expenditures by types of cancers
Type of cancer Cases Direct expenditure Indirect expenditure
LNmean LNSD Mean (RMB) LNmean LNSD Mean (RMB)
Lung cancer 50 2.20 0.14 8505.77 1.87 0.25 651.96
Stomach cancer 47 2.26 0.12 14627.70 1.96 0.16 1234.37
Colorectal cancer 41 2.23 0.13 10584.85 1.86 0.21 616.44
Esophageal cancer 27 2.22 0.13 10317.53 1.88 0.20 714.95
Cervical cancer 24 2.25 0.11 12741.51 1.99 0.11 1520.87
Other cancer 129 2.21 0.12 9482.52 1.94 0.18 1054.51
P values 0.208 0.014
All Cancers 318 2.224 0.124 10365.136 1.922 0.194 929.863
Note: LNmean the mean of Ln(Ln(x)), where x stands for individual health expenditures, RMB stands for Chinese yuan, the power for the differences in per-case in-
patient care expenditures among different types was calculated using ANOVA
Appendix 1
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Appendix 2
Additional file
Additional file 1: Raw dataset of inpatient cancer care costs and related
variables studied. (XLSX 32 kb)
Abbreviation
ICC: inpatient cancer care; FBC: financial burden of cancers; SD: standard
deviations; URMI: urban and rural medical insurance.
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Table 7 Per-case inpatient cancer care expenditures by different groups of patients
Grouping criteria Direct expenditure Indirect expenditure
LNmean LNSD Mean (RMB) LNmean LNSD Mean (RMB)
Age (years)
Under 45 2.23 0.12 10743.79 1.95 0.20 1162.20
45 to 54 2.24 0.13 12225.86 2.02 0.16 1843.87
55 to 64 2.20 0.12 8423.02 1.85 0.20 578.89
65 to 74 2.26 0.12 14231.26 1.93 0.19 975.59
75 or over 2.21 0.11 9126.47 1.93 0.14 957.97
P value 0.075 <0.001
Type of health insurance
NCMC 2.21 0.12 8907.97 1.91 0.20 872.20
CEMI 2.26 0.11 14846.80 1.93 0.20 998.14
CRMI 2.20 0.11 8096.26 1.88 0.12 681.10
URMI 2.25 0.17 13183.24 2.02 0.19 1943.92
Others 2.31 0.15 23120.53 2.00 0.26 1577.44
P value 0.001 0.043
Household income (quartile)
Q1 2.18 0.13 7200.36 1.86 0.24 636.12
Q2 2.23 0.11 11243.20 1.95 0.17 1104.75
Q3 2.23 0.12 10980.39 1.91 0.17 852.85
Q4 2.25 0.13 12977.18 1.96 0.19 1243.66
P value 0.009 0.051
Level of hospital
Township 2.04 0.13 2142.30 1.66 0.43 193.00
County 2.19 0.11 7700.41 1.86 0.17 613.14
Prefecture 2.25 0.12 12974.11 1.98 0.16 1379.28
Provence 2.28 0.11 17132.95 1.98 0.18 1361.48
P value <0.001 <0.001
Education
No education 2.24 0.12 12125.86 1.93 0.18 993.32
Primary school 2.21 0.13 8822.87 1.90 0.21 804.18
Middle school 2.23 0.12 11409.51 1.93 0.18 975.92
Secondary or higher school 2.22 0.12 10042.12 1.94 0.18 1070.38
P value 0.245 0.551
Total 2.22 0.12 10365.14 1.92 0.19 929.86
Note: NCMC new corporative medical care, CEMI city employee medical insurance, CRMI city resident medical insurance, URMI urban and rural. RMB stands for
Chinese yuan; the power for the differences per-case inpatient cancer care expenditures among different groups was calculated using ANOVA
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